Interventional Cardiology Publications :: Nationwide Children's Hospital

Interventional Cardiology Publications

  • Holzer RJ, Sisk M, Chisolm JL, Hill SL, Olshove V, Phillips A, Cheatham JP, Galatowicz M. Completion Angiography After Cardiac Surgery for Congenital Heart Disease: Complementing the Intraoperative Imaging Modalities. Pediatr Cardiol 2009;30(8)1075-82.
  • Holzer RJ, Wood A, Chisolm JL, Hill SL, Phillips A, Galantowicz M, Cheatham JP. Atrial septal interventions in patients with hypoplastic left heart syndrome. Catheterization & Cardiovascular Interventions 72(5):696-704. 2008.
  • Holzer R, Marshall A, Kreutzer J, Hirsch R, Chisolm J, Hill S, Galantowicz M, Phillips A, Cheatham J, L Bergerson. Hybrid Procedures: Adverse Events and Procedural Characteristics – Results of a Multi-institutional Registry. Congenital Heart Dis. 2010;5:233-242 (May-June 2010).
  • Holzer RJ, Chisolm JL, Hill SL, Olshove V, Phillips A, Cheatham JP, Galantowicz M. "Hybrid" stent delivery in the pulmonary circulation. Journal of Invasive Cardiology. 2008;592-598.
  • Galantowicz M, Cheatham JP, Phillips A, Cua CL, Hoffman TM, Hill SL, Rodeman R. Hybrid approach for hypoplastic left heart syndrome: intermediate results after the learning curve. Annals of Thoracic Surgery 85(6):2063-70; discussion. 2070;-1.
  • Holzer RJ, Chisolm JL, Hill SL, Cheatham JP. Stenting complex aortic arch obstructions. Catheterization & Cardiovascular Interventions 71(3):375-82. 2008.
  • Fu YC, Bass J, Amin Z, Radtke W, Cheatham JP, Hellenbrand WE, Balzer D, Cao QL, Hijazi ZM. Transcatheter closure of perimembranous ventricular septal defects using the new Amplatzer membranous VSD occluder: results of the U.S. phase I trial. Journal of the American College of Cardiology 47(2):319-25. 2006.
  • Galantowicz M, Cheatham JP. Lessons learned from the development of a new hybrid strategy for the management of hypoplastic left heart syndrome.[republished from Pediatr Cardiol. 2005 Mar-Apr;26(2):190-9; PMID: 15906023]. Pediatric Cardiology 26(3):190-9. 2005;-Jun.
  • Bacha EA, Cao QL, Galantowicz ME, Cheatham JP, Fleishman CE, Weinstein SW, Becker PA, Hill SL, Koenig P, Alboliras E, Abdulla R, Starr JP, Hijazi ZM. Multicenter experience with perventricular device closure of muscular ventricular septal defects. Pediatric Cardiology 26(2):169-75. 2005;-Apr.
  • Holzer R, Balzer D, Cao QL, Lock K, Hijazi ZM, Amplatzer Muscular Ventricular Septal Defect Investigators. Device closure of muscular ventricular septal defects using the Amplatzer muscular ventricular septal defect occluder: immediate and mid-term results of a U.S. registry. Journal of the American College of Cardiology 43(7):1257-63. 2004.
  • Holzer R, Balzer D, Amin Z, Ruiz CE, Feinstein J, Bass J, Vance M, Cao QL, Hijazi ZM. Transcatheter closure of postinfarction ventricular septal defects using the new Amplatzer muscular VSD occluder: Results of a U.S. Registry. Catheterization & Cardiovascular Interventions 61(2):196-201. 2004.
  • Cheatham JP.  The ideal cardiac catheterization laboratory: Not Just for Cardiologists Anymore … it is Hybrid Time!  For textbook entitled Percutaneous Interventions for Congenital Heart Disease.  Editors Horst Sievert, Shakeel A. Qureshi, Neil Wilson and Ziyad Hijazi, Informa Healthcare, Abingdon, UK. pp 3-11, 2007.
  • Hill SL, Hijazii ZM, Hellenbrand WE, Cheatham JP.  Evaluation of the AMPLATZER Vascular Plug for embolization of peripheral vascular malformations associated with congenital heart disease.  Catheterization and Cardiovascular Interventions, 67:113-119, 2006.
  • Cheatham JP.  How to Build a Hybrid Congenital Heart Disease Program For textbook entitled Complications in Percutaneous Interventions For Congenital & Structural Heart Disease.  Edited by Hijazi ZM, Feldman T, Cheatham, JP, Sievert H.  Informa Healthcare, UK, pp 31-40, 2009.
Nationwide Children's Hospital
700 Children's Drive Columbus, Ohio 43205 614.722.2000